Correlation of serum Alanine transaminase level with grade of fatty liver assessed on ultrasonograph

Authors

  • Roshanay Raza Institute of Microbiology and Molecular Genetics, University of the Punjab, Lahore.
  • Um ul Baneen Zehra Institute of Microbiology and Molecular Genetics, University of the Punjab, Lahore.
  • Maham Nadeem Institute of Microbiology and Molecular Genetics, University of the Punjab, Lahore.
  • Hira Hameed Institute of Microbiology and Molecular Genetics, University of the Punjab, Lahore.
  • Nageen Hussain Institute of Microbiology and Molecular Genetics, University of the Punjab, Lahore.
  • Mujahida Arshad Institute of Microbiology and Molecular Genetics, University of the Punjab, Lahore.
  • Muhammad Bin Aslam Institute of Microbiology and Molecular Genetics, University of the Punjab, Lahore.
  • Mishkat Aslam Institute of Microbiology and Molecular Genetics, University of the Punjab, Lahore.
  • Sara Salahudin Institute of Microbiology and Molecular Genetics, University of the Punjab, Lahore.
  • khadeejah sajwani Institute of Microbiology and Molecular Genetics, University of the Punjab, Lahore.
  • Fatima Ali Institute of Microbiology and Molecular Genetics, University of the Punjab, Lahore.

DOI:

https://doi.org/10.38211/jms.2024.03.105

Keywords:

Alanine transaminase, Non-alcoholic Fatty Liver Diseas, Steatosis, Fatty Liver,, Ultrasound

Abstract

Non-alcoholic Fatty Liver Disease (NAFLD), commonly known as "Fatty Liver," is characterized by the absence of lobular inflammation and macrovesicular changes caused by inflammation (steatosis). It encompasses two subgroups: Steatosis and Non-Alcoholic Steatohepatitis, both forms of NAFL. Ultrasonography is employed to assess the grade and severity of the disease. Alanine transaminase (ALT) levels in the blood serve as biomarkers for its diagnosis. We conducted a study at the Diagnostic Centre of Combined Military Hospital in Lahore, this cross-sectional study involved 100 participants selected via convenient sampling from April 2023 to June 2023. The study aims to explore correlation between ALT levels and the grades of fatty liver detected through ultrasound. All participants undergoing abdominal ultrasound suspected of having fatty liver were included, and their ALT levels were measured. Among the 100 participants, 21% did not exhibit fatty liver, with 71.4% having normal ALT levels, 19% having ALT levels between 41-60 U/L, and 9.5% having ALT levels greater than 80 U/L. Grade 1 fatty liver was identified in 32 patients, with 34% having normal ALT levels, 62.5% having ALT levels between 41-60 U/L, and 3.1% having ALT levels greater than 80 U/L. Additionally, 26% of patients were classified as having grade 2 fatty liver, among which 26.9% had ALT levels between 41-60 U/L, and 73.1% had ALT levels falling between 60-80 U/L. Lastly, 21% of patients were categorized with grade 3 fatty liver, with 9.5% having ALT levels between 60-80 U/L, and 90.5% having ALT levels greater than 80 U/L. This study demonstrates a direct relationship between ALT levels and the seriousness of fatty liver disease, suggesting ALT as a potential biomarker for assessing disease progression.

References

Abangah, G., Yousefi, A., Asadollahi, R., Veisani, Y., Rahimifar, P., & Alizadeh, S. (2014). Correlation of body mass index and serum parameters with ultrasonographic grade of fatty change in non-alcoholic fatty liver disease. Iranian Red Crescent Medical Journal, 16(1), e12669.

Ahn, E., & Kang, H. (2018). Introduction to systematic review and meta-analysis. Korean journal of anesthesiology, 71(2), 103-112.

Ballestri, S., Lonardo, A., Romagnoli, D., Carulli, L., Losi, L., Day, C. P., & Loria, P. (2012). Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. Liver International, 32(8), 1242-1252.

Ballestri, S., Romagnoli, D., Nascimbeni, F., Francica, G., & Lonardo, A. (2015). Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications. Expert review of gastroenterology & hepatology, 9(5), 603-627.

Bang, K. B., & Cho, Y. K. (2015). Comorbidities and metabolic derangement of NAFLD. Journal of lifestyle medicine, 5(1), 7.

Bedossa, P., & Poynard, T. (1996). An algorithm for the grading of activity in chronic hepatitis C. Hepatology, 24(2), 289-293.

Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999). Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Official journal of the American College of Gastroenterology| ACG, 94(9), 2467-2474.

Buffie, C. G., & Pamer, E. G. (2013). Microbiota-mediated colonization resistance against intestinal pathogens. Nature Reviews Immunology, 13(11), 790-801.

Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K.,…Sanyal, A. J. (2012). The diagnosis and management of non‐alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology, 55(6), 2005-2023.

Fisher, L., Srikusalanukul, W., Fisher, A., & Smith, P. (2015). Liver function parameters in hip fracture patients: relations to age, adipokines, comorbidities and outcomes. International Journal of Medical Sciences, 12(2), 100.

Fracanzani, A. L., Valenti, L., Bugianesi, E., Andreoletti, M., Colli, A., Vanni, E., Marchesini, G. (2008). Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology, 48(3), 792-798.

Goudarzi, H., Heidarianpour, A., & Keshvari, M. (2024). Effect of 12 Weeks of Combined Training on the Serum Levels of Nesfatin-1 and Some Liver Enzymes in Men with Non-Alcoholic Fatty Liver Disease. Journal of Arak University of Medical Sciences, 27(2), 106-114.

Hamaguchi, M., Kojima, T., Itoh, Y., Harano, Y., Fujii, K., Nakajima, T., da, K. (2007). The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Official journal of the American College of Gastroenterology| ACG, 102(12), 2708-2715.

Hernaez, R., Lazo, M., Bonekamp, S., Kamel, I., Brancati, F. L., Guallar, E., & Clark, J. M. (2011). Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta‐analysis. Hepatology, 54(3), 1082-1090.

Khov, N., Sharma, A., & Riley, T. R. (2014). Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease. World journal of gastroenterology: WJG, 20(22), 6821.

Kim, W. R., Flamm, S. L., Di Bisceglie, A. M., & Bodenheimer, H. C. (2008). Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology, 47(4), 1363-1370.

Kunde, S. S., Lazenby, A. J., Clements, R. H., & Abrams, G. A. (2005). Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women. Hepatology, 42(3), 650-656.

Lu, H., Liu, H., Hu, F., Zou, L., Luo, S., & Sun, L. (2013). Independent association between nonalcoholic fatty liver disease and cardiovascular disease: a systematic review and meta‐analysis. International journal of endocrinology, 2013(1), 124958.

Ma, X., Liu, S., Zhang, J., Dong, M., Wang, Y., Wang, M., & Xin, Y. (2020). Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis. BMC gastroenterology, 20, 1-8.

Ma, Y., Li, J., Wang, H., Chiu, Y., Kingsley, C. V., Fry, D., Maitra, A. (2020). Combination of PD-1 inhibitor and OX40 agonist induces tumor rejection and immune memory in mouse models of pancreatic cancer. Gastroenterology, 159(1), 306-319. e312.

Martin-Rodriguez, J. L., Gonzalez-Cantero, J., Gonzalez-Cantero, A., Arrebola, J. P., & Gonzalez-Calvin, J. L. (2017). Diagnostic accuracy of serum alanine aminotransferase as biomarker for nonalcoholic fatty liver disease and insulin resistance in healthy subjects, using 3T MR spectroscopy. Medicine, 96(17), e6770.

Shannon, A., Alkhouri, N., Carter-Kent, C., Monti, L., Devito, R., Lopez, R., Nobili, V. (2011). Ultrasonographic quantitative estimation of hepatic steatosis in children with NAFLD. Journal of pediatric gastroenterology and nutrition, 53(2), 190-195.

Targher, G., Corey, K. E., Byrne, C. D., & Roden, M. (2021). The complex link between NAFLD and type 2 diabetes mellitus—mechanisms and treatments. Nature reviews Gastroenterology & hepatology, 18(9), 599-612.

Thakur, S., Kumar, V., Das, R., Sharma, V., & Mehta, D. K. (2024). Biomarkers of hepatic toxicity: an overview. Current Therapeutic Research, 100737.

Thong, V. D., & Quynh, B. T. H. (2021). Correlation of serum transaminase levels with liver fibrosis assessed by transient elastography in vietnamese patients with nonalcoholic fatty liver disease. International Journal of General Medicine, 1349-1355.

Washington, I. M., & Van Hoosier, G. (2012). Clinical biochemistry and hematology. In The laboratory rabbit, guinea pig, hamster, and other rodents (pp. 57-116). Elsevier.

Wilkins, T., Tadkod, A., Hepburn, I., & Schade, R. R. (2013). Nonalcoholic fatty liver disease: diagnosis and management. American family physician, 88(1), 35-42.

Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016). Global epidemiology of nonalcoholic fatty liver disease—meta‐analytic assessment of prevalence, incidence, and outcomes. Hepatology, 64(1), 73-84.

Zheng, J.-R., Wang, Z.-L., Jiang, S.-Z., Chen, H.-S., & Feng, B. (2023). Lower alanine aminotransferase levels are associated with increased all-cause and cardiovascular mortality in nonalcoholic fatty liver patients. World journal of hepatology, 15(6), 813

Downloads

Published

2024-12-30

How to Cite

Raza, R., Um ul Baneen Zehra, Nadeem, M., Hameed, H., Hussain, N., Arshad, M., … Ali, F. (2024). Correlation of serum Alanine transaminase level with grade of fatty liver assessed on ultrasonograph. Journal of Microbiological Sciences, 3(01), 58–65. https://doi.org/10.38211/jms.2024.03.105

Issue

Vol. 3 No. 01 (2024): Journal of Microbiological Sciences

Section

Research Articles

License

Copyright (c) 2024 Roshanay Raza, Um ul Baneen Zehra, Maham Nadeem, Hira Hameed, Nageen Hussain, Mujahida Arshad, Muhammad Bin Aslam, Mishkat Aslam, Sara Salahudin, khadeejah sajwani, Fatima Ali

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.